References
- Silber S, Albertsson P, Avilés FF et al. Task Force of Percutaneous Coronary Interventions of the European Society of Cardiology: guidelines for percutaneous coronary interventions. Eur Heart J. 2005; 26(8): 804-847. PubMed | Google Scholar
- King SB, Smith SC, Hirshfeld JW Jr et al. Focused Update of the ACC/AHA/SCAI 2005 Guidelines update of Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task force of Practice Guidelines. Circulation. 2008; 117(2): 261-295. PubMed | Google Scholar
- Serruys PW, Morice MC, Kappetein P et al. Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery Disease. N Engl J Med. 2009; 360(10): 961-972. PubMed | Google Scholar
- Tamburino C, Di Salvo ME, Capodanno D et al. Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? insights from a multicentre registry. Eur Heart J. 2009; 30(10): 1171-1179. PubMed | Google Scholar
- Migliorini A, Moschi G, Guiarlani L et al. Drug-Eluting Stent Supported Percutaneous Coronary Intervention for Unprotected Left Main Disease. Catheter Cardiovasc Interv. 2006; 68(2): 225-230. PubMed | Google Scholar
- Valgimigli M, Malagutti P, Aoki J et al. Sirolimus-Eluting Versus Paclitaxel-Eluting Stent Implantation for the Percutaneous Treatment of Left Main Coronary Artery Disease: a Combined RESEARCH and T-SEARCH Long-Term Analysis. JACC. 2006; 47(3): 507-514. PubMed | Google Scholar
- Montalescot G, Brieger D, Eagle KA et al. Unprotected left main revascularization in patients with acute coronary artery syndromes. Eur Heart J. 2009; 30(19): 2308-2317. Google Scholar
- Palmerini T, Marzocchi A, Marrozzini C, et al. Comparison Between Coronary Angioplasty and Coronary Baypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna registry). Am J Cardiol. 2006; 98(1): 54-59. PubMed | Google Scholar
- Tanigawa J, Sutaria N, Goktekin O, Di Mario C. Treatment of Unprotected Left Main Coronary Artery Stenosis in the Drug-Eluting Stent Era. J Interven Cardiol. 2005; 18(6): 455-465. PubMed | Google Scholar
- Black A, Cortina R, Bossi I et al. Unprotected Left Main Coronary Artery Stenting Correlates of Midterm Survival and Impact of Patient Selection. JACC. 2001; 37(3): 832-838. PubMed | Google Scholar
- Taggart DP, Kaul S, Boden WE et al. Revascularization of Unprotected Left Main Stem Coronary Artery Stenosis: stenting or surgery. JACC. 2008; 51(9): 885-892. PubMed | Google Scholar
- Lee MS, Kapoor N, Jamal F et al. Comparison of Coronary Artery Baypass With Percutaneous Coronary Intervention With Drug-Eluting Stents for Unprotected Left Main Coronary Artery Disease. JACC. 2006; 47(4): 864-870. PubMed | Google Scholar
- Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery of unprotected left main stenosis: a single center experience. Circulation. 2006; 113(21): 2542-2547. PubMed | Google Scholar
- Seung KB, Park DW, YH Kim et al. Stents versus Coronary-Artery Baypass Grafting for Left Main Coronary Artery Disease. N Engl J Med. 2008; 358(17): 1781-1792. PubMed | Google Scholar
- Price MJ, Cristea E, Sawhney N et al. Serial angiographic follow-up of Sirolimus-eluting stents for unprotected left main coronary artery revascularisation. J Am Coll Cardiol. 2006; 47(4): 871-877. PubMed | Google Scholar
- Valgimigli M, Malagutti P, Rodriguez-Granillo GA et al. Distal left main coronary disease is a major predictor of outcome in patients undergoing percutaneous intervention with drug-eluting stent era: an integrated clinical and angiographic analysis based on the RESEARCH and T-SEARCH registries. J Am Coll Cardiol. 2006; 47(8): 1530-1537. PubMed | Google Scholar
- Chieffo A, Park SJ, Valgimigli M et al. Favorable long terme outcome after drug eluting-stent implantation in non-bifurcation lesions that involve unprotected left main coronary artery: a multicenter registry. Circulation. 2007; 116(2): 158-162. PubMed | Google Scholar
- Park SJ, Kim YH, Lee BK et al. Sirolimus-Eluting Stent Implantation for Unprotected Left Main Coronary Stenosis Comparison With Bare-Metal Stent Implantation. JACC. 2005; 45(3): 351-356. PubMed | Google Scholar
- Morice MC, Serruys PW, Sousa JE et al. Randomized Study with the Sirolimus coated Bx Velocity Balloon-Epandable Stent in the Treatment of the patients with a Novo Native Coronary Artery Lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularisation. N Engl J Med. 2002; 346(23): 1773-1780. PubMed | Google Scholar
- Moses JW, Leon MB, Popma JJ et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349(14): 1315-1323. PubMed | Google Scholar
- Stone GW, Ellis SG, Cox DA et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004, 350(3): 221-231. PubMed | Google Scholar
- Valgimigli M, Mieghem CA, Ong AT et al. Short and long term clinical outcome after drug eluting-stent implantation for percutaneous treatment of left main coronary artery disease: insights from the rapamycin-eluting stent and taxus stent evaluated at Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005; 111(11): 1383-1389. PubMed | Google Scholar